Transforming growth factor-beta (TGF-beta) has been implicated to part
icipate in heart development. The receptors which transduce the signal
(s) mediated by TGF-beta ligand binding have only recently been cloned
. One of the most prominent effects of TGF-beta is inhibition of cell
proliferation, a process that is tightly regulated during heart develo
pment. Using the developing rat ventricle as a model system, we have d
etermined the steady state expression patterns for the Type I, II, and
III TGF-beta receptors (TGF-beta Rs). Using RNA isolated from ventric
ular chambers on day 18 of gestation through the ninth postnatal week
of age, we detected a modest increase in expression levels for Type I
and Type III TGF-beta Rs. In contrast, steady state transcript levels
for the Type II TGF-beta R showed a profound developmental increase fr
om nearly undetectable levels at the fetal ages examined to high level
s during the first postnatal week of age. Immunoelectron microscopic l
ocalization of Type II TGF-beta R confirmed that the 3-week-old ventri
cular myocyte, as well as nonmyocytes, contained immunoreactive materi
al. Immunoreactivity was found at both the cell surface as well as int
racellular compartment. Regional variations (right ventricle, left ven
tricle, or septum) in the expression pattern of several markers of hea
rt development, but not the TGP-beta R's, were found in RNA obtained f
rom 3-week-old postnatal animals. These data suggest that ''downstream
'' effecters of TGF-beta-mediated stimulation are modulated in a devel
opmental, regional-specific manner in the neonatal/mature myocardium b
y the level of bioactive TGF-beta.